Consiglio Nazionale delle Ricerche
Posted: 18 October 2026 - Rome, Italy
The MITCAN project aims to develop anti-cancer drugs targeting the GRASP65–GM130 axis, a pathway crucial for the mitotic spindle and chromosomal stability. The role involves characterizing protein-protein interfaces, analyzing druggability, and employing virtual screening campaigns. Responsibilities also include scientific reporting and providing methodological mentoring.